Literature DB >> 23688537

Inpatient management of diabetes and hyperglycemia.

Magdalena Bogun1, Silvio E Inzucchi.   

Abstract

Illness, particularly when severe, leads to increased concentrations of counter-regulatory factors which induce insulin resistance and predispose patients to stress hyperglycemia. Elevated glucose concentrations are common in hospitalized patients, both those with as well as without recognized diabetes. Substantial data has emerged over the past decade that quality glucose management in these individuals actually improves clinical outcomes. Controlling glucose in this setting is challenging, given the phenotypic variability amongst patients, with fluctuating courses of acute illnesses and unpredictable nutritional schedules. We review the evidence basis that has informed national standards and glucose targets in both critically and non-critically ill patients. In the intensive care setting, insulin infusions are now widely endorsed to quickly achieve and maintain glucose control. On the hospital wards, physiological subcutaneous insulin therapy, incorporating both basal and nutritional components, is emerging as the optimal treatment strategy. The transition to outpatient care is another important aspect of any hospital glycemic management program.
Copyright © 2013. Published by EM Inc USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23688537     DOI: 10.1016/j.clinthera.2013.04.008

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  7 in total

1.  Hypoglycemia Incidence and Factors Associated in a Cohort of Patients With Type 2 Diabetes Hospitalized in General Ward Treated With Basal Bolus Insulin Regimen Assessed by Continuous Glucose Monitoring.

Authors:  Ana María Gómez; Angélica Imitola Madero; Diana Cristina Henao Carrillo; Martín Rondón; Oscar Mauricio Muñoz; Maria Alejandra Robledo; Martín Rebolledo; Maira García Jaramillo; Fabian León Vargas; Guillermo Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2019-01-24

2.  The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutrition.

Authors:  Joseph F Pierre; Joshua C Neuman; Allison L Brill; Harpreet K Brar; Mary F Thompson; Mark T Cadena; Kelsey M Connors; Rebecca A Busch; Aaron F Heneghan; Candace M Cham; Elaina K Jones; Carly R Kibbe; Dawn B Davis; Guy E Groblewski; Kenneth A Kudsk; Michelle E Kimple
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-07-16       Impact factor: 4.052

3.  Using the glucometrics website to benchmark ICU glucose control before and after the NICE-SUGAR study.

Authors:  Ranee R Lleva; Prem Thomas; Janis E Bozzo; Karrie C Hendrickson; Silvio E Inzucchi
Journal:  J Diabetes Sci Technol       Date:  2014-07-10

4.  Effect of Average Blood Glucose Greater Than 140 mg/dL on Adverse Patient Outcomes in Adult Medical/Surgical Patients.

Authors:  Morgan A Wynes; Jaclyn A Boyle
Journal:  Innov Pharm       Date:  2021-02-15

5.  Medication Errors and Type 2 Diabetes Management: A Qualitative Exploration of Physicians' Perceptions, Experiences and Expectations From Quetta City, Pakistan.

Authors:  Muhammad Kashif Habib; Muhammad Naeem Khan; Abdul Sadiq; Qaiser Iqbal; Abdul Raziq; Nafees Ahmad; Zaffar Iqbal; Sajjad Haider; Muhammad Anwar; Fazal Ur Rehman Khilji; Fahad Saleem; Amer Hayat Khan
Journal:  Front Med (Lausanne)       Date:  2022-03-28

6.  Machine Learning Prediction of Hypoglycemia and Hyperglycemia From Electronic Health Records: Algorithm Development and Validation.

Authors:  Alexander Benedikt Leichtle; Harald Witte; Christos Nakas; Lia Bally
Journal:  JMIR Form Res       Date:  2022-07-18

Review 7.  CGM in the Hospital: Is It Ready for Prime Time?

Authors:  Elizabeth O Buschur; Eileen Faulds; Kathleen Dungan
Journal:  Curr Diab Rep       Date:  2022-07-07       Impact factor: 5.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.